Key result
The Japanese version of the KCCQ demonstrated good construct validity, high internal consistency (Cronbach's α > 0.70), and substantial responsiveness to clinical changes in patients with chronic heart failure.
Why the study?
Heart failure significantly affects physical function and health status, and the psychometric properties of the Japanese version of the KCCQ required evaluation.
Observational (n=141)
Yes
The Japanese version of the KCCQ is a valid, reliable, and responsive tool for assessing symptoms and physical function in Japanese patients with chronic heart failure.
Supports KCCQ use for Japanese HF symptom monitoring; extends validation to non-English populations.
BACKGROUND: Heart failure is a worldwide health problem that significantly affects patients' physical function and health state. The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a disease-specific patient-reported outcome measure commonly used for the assessment of health states of patients with heart failure. This study aimed to evaluate the psychometric properties of the Japanese version of the KCCQ. METHODS: Using pooled data of 141 Japanese patients with chronic heart failure from three clinical trials, the Japanese version of the KCCQ was evaluated for validity and reliability, with a focus on the clinical summary score (CSS) and its component domains. For construct validity, the associations of baseline KCCQ scores with New York Heart Association (NYHA) class and the EuroQol five-dimension, three-level (EQ-5D-3L) scores at baseline were analyzed. For reliability, internal consistency was assessed using Cronbach's α, and test-retest reliability (reproducibility) was assessed among stable patients. Responsiveness to changes in patients' clinical status was assessed by analyzing score changes between two timepoints among patients whose health states improved. RESULTS: Among 141 patients (mean age, 73.7 ± 10.9 years), 76.6% were NYHA class II at baseline. For CSS and its component domains (physical limitations, symptom frequency, and symptom severity), baseline scores were all significantly lower in patients with a higher NYHA class (p < 0.001 for all, Jonckheere-Terpstra test). The physical limitations domain and CSS showed a moderate correlation (Spearman's ρ = - 0.40 to - 0.54) with three functional status-related EQ-5D dimensions (mobility, self-care, and usual activities). The Cronbach's standardized α was high (> 0.70) for all KCCQ domain/summary scores. In the test-retest analysis among 58 stable patients, all domain/summary scores minimally changed by 0.3-4.2 points with intraclass correlation coefficients of 0.65-0.84, demonstrating moderate to good reproducibility, except for the symptom stability domain. Among 44 patients with improved health states, all domain/summary scores except for the symptom stability and self-efficacy domains substantially improved from baseline with a medium to large effect size of 0.62-0.88. CONCLUSIONS: The Japanese version of the KCCQ was demonstrated to be a valid and reliable tool for the assessment of symptoms and physical function of Japanese patients with chronic heart failure.
No takes yet. Share an insight, caveat, or question.
Watanabe-Fujinuma et al. (2020) conducted an observational in Chronic heart failure (n=141). Japanese version of the Kansas City Cardiomyopathy Questionnaire (KCCQ) was evaluated on Psychometric properties (validity, reliability, and responsiveness) of the Japanese KCCQ. The Japanese version of the KCCQ demonstrated good construct validity, high internal consistency (Cronbach's α > 0.70), and substantial responsiveness to clinical changes in patients with chronic heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: